InsidersTradesSigma
Follow the LIG아큐버 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, LIG아큐버 has published 1 reports. Market capitalisation: €216.7bn. The latest transaction was filed on 30 April 2026 (Purchase). Among the most active insiders: 허순재. The full history is free.
Analysts rate LIG아큐버 Buy (bullish), based on 1 analysts. Average price target: ₩50,000.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
LIG아큐버 is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions to enhance healthcare.